C

E

CONCIA , E.

Last name: CONCIA

First name: E.

2016 (v1)

Publication

Metadata-only

Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections

Russo, A. Concia, E. Cristini, F.

In 2013 the US Food and Drug Administration (FDA) issued recommendations and guidance on developing drugs for treatment of skin infection using a new definition of acute bacterial skin and skin-structure infection (ABSSSI). The new classification includes cellulitis, erysipelas, major skin abscesses and wound infection with a considerable...

Uploaded on: April 14, 2023
2017 (v1)

Publication

Metadata-only

Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Di Giambenedetto, S. Fabbiani, M. Quiros Roldan, E.

Background: Combination ART (cART)-related toxicities and costs have prompted the need for treatment simplification. The ATLAS-M trial explored 48 week non-inferior efficacy of simplification to atazanavir/ritonavir + lamivudine versus maintaining three-drug atazanavir/ritonavir-based cART in virologically suppressed patients. Methods: We...

Uploaded on: April 14, 2023